ufacture more than 40 million doses EFTA00150545 annually in Cairo." According to the AP, the Russian Direct Investment Fund, "along with Egypt's Minapharm and its Berlin-based subsidiary, issued a joint press release saying the technology transfer will begin immediately. It expects the roll out of the